17.60USD-3.32%Mkt Cap: 916.85M USDP/E: —Last update: 2026-06-01
Seaport Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines. The company develops therapeutic candidates for conditions such as depressi…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap916.85M USD
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-74.88M USD
Revenue/Share—
Last Price17.60 USD
Fiscal Year EndDec 2025
MR Quarter—
Employees58
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-7.52
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-1.60
EPS (TTM)-1.94
EPS (Forward)-2.42
52W Range
14.8534% of range23.00
52W High23.00 USD
52W Low14.85 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE80.91%
ROA-30.07%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-77.94M USD
CapEx (TTM)356.00K USD
FCF Margin—
FCF Yield-5.54%
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.05
Current Ratio17.46
Quick Ratio17.13
Book Value/Sh-11.3540 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)35.50 USD
Target Range30.00 USD – 42.00 USD
# Analysts4
Ownership
Shares Out.53.03M
Float2.89M
Insiders35.39%
Institutions28.64%
Short Interest
Short Ratio1.6d
Short % Float2.89%
Short % Out.2.75%
Shares Short1.46M
Technical
SMA 5016.84 (+4.5%)
SMA 20016.84 (+4.5%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)551.07K
Avg Vol (10d)261.16K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—